Diclofenac Sodium And Misoprostol Tablet, Delayed Release
Product Images NDC 0591-0397

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium And Misoprostol (NDC 0591-0397). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

50mg-0.2mg_60s (Teva Image 1)

Label for Diclofenac Sodium and Misoprostol Delayed-Release Tablets USP, 50 mg/0.2 mg strength, oral dosage form. The label indicates a package count of 60 tablets, prescription use only, and includes pharmacy dispensing instructions. The label warns against use during pregnancy and provides storage conditions. Manufactured by Teva Pharmaceuticals, Parsippany, NJ. The label features a barcode and a lot/expiration/serialization coding area.*

FDA Label Image

75mg-0.2mg_60s (Teva Image 2)

Label for Diclofenac Sodium and Misoprostol Delayed-Release Tablets USP, 75 mg/0.2 mg strength. The label indicates a package of 60 tablets, prescription only, with storage instructions and a boxed warning about pregnancy. Manufacturer is Teva Pharmaceuticals, Parsippany, NJ. Includes NDC 0591-0398-60 and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.